Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Direct Meds reflects a consumer-facing pricing model that positions the platform competitively within the compounded GLP-1 telehealth market
J Mol Endocrinol 2020;64:103-13.ArticlePubMed REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Related articles Anthropometric Changes and Risk of Visual Impairment in Patients with Newly Diagnosed Type 2 Diabetes Mellitus High Waist-to-Height Ratio Increases the Risk of Cardiovascular Outcomes in Adults with Type 1 Diabetes Mellitus: A Nationwide Cohort Study Glucagon-Like Peptide-1 Receptor Agonists: Whats the Optimizing Policies for Obesity-Related Metabolic Diseases
Another fiber ingredient, resistant starch, stimulates the bodys production of the GLP-1 hormone
A 500 mcg dose would be 0.1 mL, or 10 units
Common side effects reported in clinical literature include nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite
Also the PBMs and pharmaceutical companies are overpricing this medicine which is creating compounded versions not approved by FDA
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
